Volume 21, Number 9—September 2015
Dispatch
Follow-up of Contacts of Middle East Respiratory Syndrome Coronavirus–Infected Returning Travelers, the Netherlands, 2014
Madelief Mollers1, Marcel Jonges1, Suzan D. Pas, Annemiek A. van der Eijk, Kees Dirksen, Casper Jansen, Luc B.S. Gelinck, Eliane M.S. Leyten, Ingrid Thurkow, Paul H.P. Groeneveld, Arianne B. van Gageldonk-Lafeber, Marion Koopmans, Aura Timen
, and for the MERS-CoV Outbreak Investigation Team of the Netherlands
, and for the MERS-CoV Outbreak Investigation Team of the Netherlands
Table 1
Laboratory results and compliance of follow-up among 131 unprotected and protected contacts of 2 patients with imported MERS-CoV infections, the Netherlands, 2014*
| Type of contact | No. persons | Male sex, % | Median age, y (range) | No. (%) contacts |
||||
|---|---|---|---|---|---|---|---|---|
| First throat swab sample | Paired throat swab sample | First serum sample | Paired serum sample | Symptomatic | ||||
| Unprotected contacts | 78 | 40 | 45 (1–78) | 77 (99) | 77 (99) | 77 (99) | 67 (86) | 7 (9) |
| Travel group | 29 | 45 | 52 (9–70) | 29 (100) | 29 (100) | 29 (100) | 28 (97) | 2 (7) |
| Aircraft contacts | 17 | 47 | 39 (7–78) | 17 (100) | 17 (100) | 17 (100) | 14 (82) | 2 (12) |
| Other contacts† |
32 |
32 |
44 (1–64) |
31 (97) |
31 (97) |
31 (97) |
25 (78) |
3 (9) |
| Protected contacts |
53 |
34 |
36 (18–63) |
44 (83) |
29 (55) |
53 (100) |
32 (60) |
1 (2) |
| Total contacts | 131 | 37 | 41 (1–78) | 121 (92) | 106 (81) | 130 (99) | 99 (76) | 8 (6) |
*MERS-CoV, Middle East respiratory syndrome coronavirus.
†Other contacts were those who had contact with the case-patients after their return to the Netherlands: 28 relatives, plus 4 persons at a general medical practice and the hospital emergency department, including 1 health care worker.
1These authors contributed equally to this article.
2Members of this team are listed at the end of this article.
Page created: August 14, 2015
Page updated: August 14, 2015
Page reviewed: August 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.